Cargando…

Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study

Alzheimer's disease (AD) is the most common type of dementia, with increasing prevalence and no disease-modifying treatment available yet. There is increasing evidence—from interventions targeting mitochondria—that may shed some light on new strategies for the treatment of AD. Previously, using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanova, Natalia A., Ershov, Nikita I., Kolosova, Nataliya G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664545/ https://www.ncbi.nlm.nih.gov/pubmed/31396299 http://dx.doi.org/10.1155/2019/3984906

Ejemplares similares

SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer’s Disease-Like Pathology in OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2020)

Changes in Glial Support of the Hippocampus during the Development of an Alzheimer’s Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2022)

The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats
por: Kolosova, Nataliya G., et al.
Publicado: (2012)

Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity
por: Muraleva, Natalia A., et al.
Publicado: (2019)

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland
por: Bakeeva, Lora E., et al.
Publicado: (2016)

Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents
por: Anisimov, Vladimir N., et al.
Publicado: (2011)

Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure
por: Vays, Valeriya B., et al.
Publicado: (2014)

Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats
por: Obukhova, Lidia A., et al.
Publicado: (2009)

Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
por: Sud’ina, Galina F., et al.
Publicado: (2022)

The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation
por: Weniger, Maximilian, et al.
Publicado: (2016)

Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis
por: Andreev-Andrievskiy, Alexander A., et al.
Publicado: (2016)

Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression
por: Markovets, Anton M., et al.
Publicado: (2011)

Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome
por: Zernii, Evgeni Yu., et al.
Publicado: (2017)

Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis
por: Fetisova, Elena K., et al.
Publicado: (2019)

The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy
por: Perepechaeva, M. L., et al.
Publicado: (2014)

Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice
por: Demyanenko, Ilya A., et al.
Publicado: (2015)

Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice
por: Demyanenko, Ilya A., et al.
Publicado: (2017)

Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria
por: Jia, Bo, et al.
Publicado: (2022)

Mitochondria-Targeted Antioxidant SkQ1 Prevents the Development of Experimental Colitis in Mice and Impairment of the Barrier Function of the Intestinal Epithelium
por: Fedorov, Artem V., et al.
Publicado: (2022)

An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology
por: Stefanova, Natalia A., et al.
Publicado: (2016)

Treating Neurodegenerative Disease with Antioxidants: Efficacy of the Bioactive Phenol Resveratrol and Mitochondrial-Targeted MitoQ and SkQ
por: Shinn, Lindsey J., et al.
Publicado: (2021)

Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis
por: Rademann, Pia, et al.
Publicado: (2017)

The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer’s Disease-like Pathology
por: Stefanova, Natalia A., et al.
Publicado: (2023)

Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1
por: Shabalina, Irina G., et al.
Publicado: (2017)

Mitochondrion-targeted antioxidant SkQ1 prevents rapid animal death caused by highly diverse shocks
por: Skulachev, V. P., et al.
Publicado: (2023)

SkQ1 treatment and food restriction — two ways to retard an aging program of organisms
por: Skulachev, Vladimir P.
Publicado: (2011)

Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
por: Dvoretskaya, Yuliya, et al.
Publicado: (2021)

Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats
por: Stefanova, Natalia A., et al.
Publicado: (2018)

Genetic Variability of the AcrAB-TolC Multidrug Efflux Pump Underlies SkQ1 Resistance in Gram-Negative Bacteria
por: Nazarov, P. A., et al.
Publicado: (2019)

Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
por: Stefanova, Natalia A., et al.
Publicado: (2014)

Delayed Formation of Neonatal Reflexes and of Locomotor Skills Is Associated with Poor Maternal Behavior in OXYS Rats Prone to Alzheimer’s Disease-like Pathology
por: Kozlova, Tatiana, et al.
Publicado: (2022)

Postnatal Maturation of the Blood–Brain Barrier in Senescence-Accelerated OXYS Rats, Which Are Prone to an Alzheimer’s Disease-like Pathology
por: Rudnitskaya, Ekaterina, et al.
Publicado: (2023)

SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
por: Petrov, Anton, et al.
Publicado: (2016)

Mitochondria-targeted antioxidant SKQ1 protects cornea from oxidative damage induced by ultraviolet irradiation and mechanical injury
por: Zernii, Evgeni Yu., et al.
Publicado: (2018)

MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2021)

Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis
por: Song, Jiayu, et al.
Publicado: (2022)

The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface
por: Wei, Yi, et al.
Publicado: (2018)

Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling
por: Otsuka, Kenji, et al.
Publicado: (2015)

Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer’s Disease
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2021)

Cognitive Training as a Potential Activator of Hippocampal Neurogenesis in the Rat Model of Sporadic Alzheimer’s Disease
por: Burnyasheva, Alena O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ktt7094ovh7f5e6n70eaoh39eb